GB202117511D0 - Treatment regimens - Google Patents
Treatment regimensInfo
- Publication number
- GB202117511D0 GB202117511D0 GBGB2117511.2A GB202117511A GB202117511D0 GB 202117511 D0 GB202117511 D0 GB 202117511D0 GB 202117511 A GB202117511 A GB 202117511A GB 202117511 D0 GB202117511 D0 GB 202117511D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment regimens
- regimens
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2117511.2A GB202117511D0 (en) | 2021-12-03 | 2021-12-03 | Treatment regimens |
AU2022251843A AU2022251843A1 (en) | 2021-03-29 | 2022-03-29 | <i>A PI3K-DELTA INHIBITOR FOR USE IN TREATMENT REGIMENS</i> |
PCT/EP2022/058283 WO2022207646A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for use in treatment regimens |
PCT/EP2022/058296 WO2022207648A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for the treatment of pancreatic cancer |
US18/271,196 US20240058351A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for use in treatment regimens |
CA3212522A CA3212522A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for the treatment of pancreatic cancer |
CN202280022613.8A CN116997340A (en) | 2021-03-29 | 2022-03-29 | PI 3K-delta inhibitors for the treatment of pancreatic cancer |
AU2022250707A AU2022250707A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for the treatment of pancreatic cancer |
CN202280022612.3A CN117042778A (en) | 2021-03-29 | 2022-03-29 | PI 3K-delta inhibitors for therapeutic regimens |
EP22719266.3A EP4313058A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for use in treatment regimens |
CA3212731A CA3212731A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for use in treatment regimens |
JP2023560325A JP2024511836A (en) | 2021-03-29 | 2022-03-29 | PI3K-delta inhibitors for the treatment of pancreatic cancer |
JP2023560623A JP2024518685A (en) | 2021-03-29 | 2022-03-29 | PI3K-DELTA INHIBITORS FOR USE IN TREATMENT REGIMENS - Patent application |
EP22719273.9A EP4313059A1 (en) | 2021-03-29 | 2022-03-29 | A pi3k-delta inhibitor for the treatment of pancreatic cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2117511.2A GB202117511D0 (en) | 2021-12-03 | 2021-12-03 | Treatment regimens |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202117511D0 true GB202117511D0 (en) | 2022-01-19 |
Family
ID=80081011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2117511.2A Ceased GB202117511D0 (en) | 2021-03-29 | 2021-12-03 | Treatment regimens |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN117042778A (en) |
GB (1) | GB202117511D0 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5735526B2 (en) * | 2009-11-13 | 2015-06-17 | メルク セローノ ソシエテ アノニム | Tricyclic pyrazoleamine derivatives |
WO2014121901A1 (en) * | 2013-02-07 | 2014-08-14 | Merck Patent Gmbh | Polymorphic forms |
-
2021
- 2021-12-03 GB GBGB2117511.2A patent/GB202117511D0/en not_active Ceased
-
2022
- 2022-03-29 CN CN202280022612.3A patent/CN117042778A/en active Pending
- 2022-03-29 CN CN202280022613.8A patent/CN116997340A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN116997340A (en) | 2023-11-03 |
CN117042778A (en) | 2023-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL272738A (en) | Treatment regimens | |
GB202108224D0 (en) | Treatment | |
GB202103122D0 (en) | Treatment | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202117511D0 (en) | Treatment regimens | |
IL304244A (en) | Synbiotic treatment regimens | |
GB202112635D0 (en) | Treatment regimen | |
GB202019215D0 (en) | Treatment regimen | |
GB202017853D0 (en) | Treatment regimen | |
GB202116743D0 (en) | Treatment | |
GB202008478D0 (en) | Treatment regimen | |
GB202114373D0 (en) | Treatment | |
GB202109815D0 (en) | Treatment | |
GB202109812D0 (en) | Treatment | |
GB202104666D0 (en) | COVID-19 treatment | |
GB202104416D0 (en) | Treatment reginmens | |
GB202103957D0 (en) | Treatment | |
GB202102488D0 (en) | Treatment | |
GB202102369D0 (en) | Treatment | |
GB202102366D0 (en) | Treatment | |
GB202102373D0 (en) | Treatment | |
GB202102410D0 (en) | Treatment | |
GB202101897D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |